Skip to main navigation Skip to search Skip to main content

Integration of genetic, clinical, and INR data to refine warfarin dosing

  • P. Lenzini
  • , M. Wadelius
  • , S. Kimmel
  • , J. L. Anderson
  • , A. L. Jorgensen
  • , M. Pirmohamed
  • , M. D. Caldwell
  • , N. Limdi
  • , J. K. Burmester
  • , M. B. Dowd
  • , P. Ngchaisuksiri
  • , A. R. Bss
  • , J. Chen
  • , N. Eriksson
  • , A. Rane
  • , J. D. Lindh
  • , J. F. Carlquist
  • , B. D. Horne
  • , G. Grice
  • , P. E. Milligan
  • C. Eby, J. Shin, H. Kim, D. Kurnik, C. M. Stein, G. McMillin, R. C. Pendleton, R. L. Berg, P. Deloukas, B. F. Gage
  • Washington University in Saint Louis School of Medicine
  • Uppsala University
  • University of Pennsylvania
  • Intermountain Medical Center
  • University of Liverpool
  • Marshfield Clinic
  • University of Alabama
  • Clinical Pharmacy Cardiac Risk Service
  • Ramathibodi Hospital
  • Hospital for Special Surgery - New York
  • Uppsala University Hospital
  • Karolinska Institutet
  • Inje University
  • Vanderbilt University
  • University of Utah School of Medicine
  • Wellcome Trust Genome Campus

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)572-578
Number of pages7
JournalClinical Pharmacology and Therapeutics
Volume87
Issue number5
DOIs
StatePublished - May 2010

ASJC Scopus Subject Areas

  • Pharmacology
  • Pharmacology (medical)

Cite this